terazosin has been researched along with Urinary Bladder, Overactive in 4 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of amlodipine, a dihydropyridine calcium-channel blocker, alone or combined with terazosin, on urodynamics in rats with benign prostatic hyperplasia (BPH) and in female rats with detrusor instability (DI)." | 7.75 | Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity. ( Chen, GL; Liu, HP; Liu, P; Xu, XP, 2009) |
| "To investigate the effects of amlodipine, a dihydropyridine calcium-channel blocker, alone or combined with terazosin, on urodynamics in rats with benign prostatic hyperplasia (BPH) and in female rats with detrusor instability (DI)." | 3.75 | Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity. ( Chen, GL; Liu, HP; Liu, P; Xu, XP, 2009) |
| "The effectiveness of overactive bladder treatment with M-cholinoblocker solifenacin (Vesicare) as monotherapy and in combination with α1-andrenoblocker terazosin (Setegis) or bladdrer training in elderly patients was evaluated." | 1.42 | [ASSESSMENT OF EFFICIENCY OF TREATMENT OF OVERACTIVE BLADDER IN ELDERLY PATIENTS]. ( Kagan, OF; Kheĭfets, VKh; Sosnovskiĭ, SO, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sosnovskiĭ, SO | 2 |
| Kheĭfets, VKh | 2 |
| Kagan, OF | 2 |
| Vaughan, CP | 1 |
| Endeshaw, Y | 1 |
| Nagamia, Z | 1 |
| Ouslander, JG | 1 |
| Johnson, TM | 1 |
| Liu, HP | 1 |
| Chen, GL | 1 |
| Liu, P | 1 |
| Xu, XP | 1 |
1 trial available for terazosin and Urinary Bladder, Overactive
| Article | Year |
|---|---|
[Peculiarities of clinical course, diagnostics and treatment of overactive bladder in men older than 60 years].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Prazosin; Prostatic H | 2014 |
3 other studies available for terazosin and Urinary Bladder, Overactive
| Article | Year |
|---|---|
[ASSESSMENT OF EFFICIENCY OF TREATMENT OF OVERACTIVE BLADDER IN ELDERLY PATIENTS].
Topics: Adrenergic alpha-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Dose-Response Relatio | 2015 |
A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.
Topics: Acetamides; Adrenergic alpha-Antagonists; Aged; Behavior Therapy; Benzhydryl Compounds; Combined Mod | 2009 |
Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Animals; Calcium Channel Blockers; Drug Therapy, Combinati | 2009 |